Inhibition of the chemokine signal regulator FROUNT by disulfiram ameliorates crescentic glomerulonephritis.
Toda E, Sawada A, Takeuchi K, Wakamatsu K, Ishikawa A, Kuwahara N, Sawa Y, Hatanaka S, Kokubo K, Makino K, Takahashi H, Endo Y, Kunugi S, Terasaki M, Terasaki Y, Matsushima K, Terashima Y, Shimizu A.
Kidney Int. 2022 Dec;102(6):1276-1290. doi: 10.1016/j.kint.2022.07.031. Epub 2022 Aug 30.
PMID:36049642
Rapidly progressive crescentic glomerulonephritis: Early treatment is a must.
Moroni G, Ponticelli C.
Autoimmun Rev. 2014 Jul;13(7):723-9. doi: 10.1016/j.autrev.2014.02.007. Epub 2014 Mar 19.
PMID:24657897
Management of crescentic glomerulonephritis: what are the recent advances?
Li X, Chen N.
Contrib Nephrol. 2013;181:229-39. doi: 10.1159/000348479. Epub 2013 May 8.
PMID:23689584
Predictors of renal outcomes in crescentic and mixed class of ANCA-associated glomerulonephritis.